Flourescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies

6Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

The velocardiofacial syndrome (VCFS), a condition associated with 22q11.2 deletions, is characterized by a typical facies, palatal anomalies, learning disabilities, behavioral disturbances and cardiac defects. We investigated the frequency of these chromosomal deletions in 16 individuals with VCFS features who presented no cardiac anomalies, one of the main characteristics of VCFS. Fluorescent in situ hybridization (FISH) with the N25 (D22S75; 22q11.2) probe revealed deletions in ten individuals (62%). Therefore, even in the absence of cardiac anomalies testing for the 22q11.2 microdeletions in individuals showing other clinical features of this syndrome is recommend. Copyright by the Brazilian Society of Genetics.

Cite

CITATION STYLE

APA

Sandrin-Garcia, P., Richieri-Costa, A., Tajara, E. H., Carvalho-Salles, A. B., & Fett-Conte, A. C. (2007). Flourescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies. Genetics and Molecular Biology, 30(1), 21–24. https://doi.org/10.1590/S1415-47572007000100006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free